Patent ID: 7041703

Claim:
A 2-aminoteraline of the formula (I) or a pharmacologically acceptable salt of the formula (II) wherein: R and R 1 are independently halogen, hydroxy, or C 1 -C 4 alkoxy optionally substituted in position ω with a group selected from OH, NH 2 or NR 3 R 4 , wherein R 3 and R 4 are independently H, C 1 -C 4 alkyl, unsubstituted or substituted in position ω with groups OH, NH 2 , C 1 -C 4 alkanoyl, C 1 -C 4 alkyl, carbamoyl, carbamoyloxy, amino, or amino-substituted NR 3 R 4 , where R 3 and R 4 have the above meanings, R 2 is hydrogen, hydroxy or methoxy, with the proviso that the 2-aminotetraline excludes (a) R═R 1 ═CH 3 O or OH, R 2 ═H, (b) R═F, R 1 ═CH 3 O or OH, R 2 ═H, (c) R 1 ═R 2 ═−OCH 3 and R 2 ═H, (d) R═R 1 ═R 2 ═CH 3 O, (e) R═R 1 ═Cl and R 2 ═H, (cf) R═R 1 −F and R 2 ═H, (g) R═OH and R 1 R 2 ═halogen, (h) R═R 1 ═OH and R 2 ═Cl or F or (i) R═R 1 ═OCH 3 and R 2 ═Cl or F, (j) R═Cl, R 1 ═OH, R 2 ═H, (k) R═MeOH, R 1 ═Cl, R 2 ═H, (l) R═Cl, R 1 ═MeOH, R 2 ═H and X − is the monovalent anion of a pharmacologically acceptable acid.